Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Subst Use Misuse ; 40(8): 1103-11, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16040371

RESUMO

Subjects maintained on methadone evidence a high level of interest in quitting cigarette smoking. Readiness to quit may result, at least partially, from direct pharmacological interactions between methadone and brain nicotinic acetylcholine receptors. The aim of the present study was to assess: (1) self-reported changes in smoking habits after admission to a methadone maintenance treatment (MMT) program; (2) acute effects of methadone administration on smoking behavior in MMT patients. The study was conducted between May and December 2001, in two public outpatient MMT clinics located in Warsaw, Poland. The patients (41 men, 30 women) reported smoking fewer cigarettes after admission to the program. Most subjects (67.6%) changed their favorite brand of cigarettes after admission. Mean nicotine content (mg/cigarette) significantly decreased. On the other hand, the subjects did not report any effects of methadone administration on smoking parameters. The above findings suggest that initiation of MMT is associated with positive changes in smoking behavior. However, these changes may not be related to direct pharmacological interactions between methadone and nicotine.


Assuntos
Metadona/uso terapêutico , Autorrevelação , Abandono do Hábito de Fumar , Fumar , Adulto , Feminino , Humanos , Masculino , Metadona/administração & dosagem , Polônia , Inquéritos e Questionários , Resultado do Tratamento
2.
J Anal Toxicol ; 29(1): 15-21, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15808008

RESUMO

It is accepted that opiates are detectable in urine within three days from the last dose at a cut-off value of 300 ng/mL. In our clinical practice, some patients tested positive for morphine even after a week of detoxification. The present study evaluates the time course of opiate excretion in urine of dependent subjects (F11.25 according to ICD-10) in relation to route of administration and a kind of street heroin. The group comprised 71 men treated for opiate dependency: 33 of them used heroin exclusively by inhalation; 26 i.v.; 12 used i.v. homemade poppy straw decoctions. Opiate levels were measured once a day by fluorescence polarization immunoassay (TDx Abbott). Detection time ranged from 3 to 10 days for cut-off value 300 ng/mL and from less than one up to seven days for cut-off value 2000 ng/mL. The increases in urine drug concentration that result from changes in urinary output may be mistakenly interpreted as a new drug use. Normalization of drug excretion to urine creatinine concentration reduces the variability of drug measurement attributable to urine dilution. The time function of creatinine normalized opiate concentration has a log-linear character, and decreases at a rate of 2.5 per day on average. New "normalized" cut-off values were proposed: 225 ng/mg creatinine, 1500 ng/mg creatinine, and 3750 ng/mg creatinine that corresponds to 300 ng/mL urine, 2000 ng/mL urine, and 5000 ng/mL urine.


Assuntos
Vias de Administração de Medicamentos , Dependência de Heroína/urina , Heroína , Imunoensaio/métodos , Entorpecentes , Detecção do Abuso de Substâncias/métodos , Creatinina/urina , Heroína/administração & dosagem , Heroína/urina , Humanos , Drogas Ilícitas/urina , Masculino , Entorpecentes/administração & dosagem , Entorpecentes/urina , Valores de Referência
3.
Przegl Lek ; 62(10): 1126, 2005.
Artigo em Polonês | MEDLINE | ID: mdl-16521970

RESUMO

There was described and discussed a case of methadone maintenance participant, former polydrug abuser, who has received a standard treatment with bupropion SR for smoking cessation. Because of substance abuse in the past, eeg was monitored. Treatment was successful: patient stays abstinent since 5 months, neither seizures nor worsening of eeg were observed.


Assuntos
Bupropiona/uso terapêutico , Inibidores da Captação de Dopamina/uso terapêutico , Dependência de Heroína/reabilitação , Metadona/uso terapêutico , Antagonistas de Entorpecentes/uso terapêutico , Abandono do Hábito de Fumar/métodos , Prevenção do Hábito de Fumar , Bupropiona/administração & dosagem , Eletroencefalografia , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos Relacionados ao Uso de Substâncias/reabilitação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA